Loading...
Annexin A2 is not a good biomarker for hepatocellular carcinoma in cirrhosis
In China, hepatocellular carcinoma (HCC) usually develops following a long history of chronic hepatitis B infection or cirrhosis. To evaluate the diagnostic role of annexin A2 (ANXA2), a possible tumor marker, in patients with hepatitis B virus (HBV)-related HCC, particularly those with a history of...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
D.A. Spandidos
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3742823/ https://ncbi.nlm.nih.gov/pubmed/23946789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2013.1337 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|